AT
PCRX icon

American Trust’s Pacira BioSciences PCRX Stock Holding History

American Trust’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,803
Closed -$255K – 470
2022
Q3 		$255K Buy
4,803
+23
+0.5% +$1.28K 0.02% 322
2022
Q2 		$279K Sell
4,780
-192
-4% -$12.6K 0.02% 325
2022
Q1 		$379K Buy
4,972
+1,079
+28% +$71.9K 0.03% 295
2021
Q4 		$234K Buy
+3,893
New +$215K 0.02% 308

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

American Trust's PCRX Position: Q4 2022 in Review

American Trust sold out of Pacira BioSciences (PCRX) in Q4 2022, closing a stake of 4,803 shares — an estimated $255K sold.

American Trust first reported a position in PCRX in Q4 2021 and held it in 4 quarters. The position peaked at $379K in Q1 2022. 273 funds tracked by Wall St. Rank hold PCRX as of Q4 2022.

  • American Trust reported no remaining Pacira BioSciences position as of Q4 2022 after selling out during the quarter.
  • American Trust sold 4,803 Pacira BioSciences shares in Q4 2022, an estimated $255K.
  • American Trust first reported a position in Pacira BioSciences in Q4 2021 and held it in 4 quarters.
  • American Trust's Pacira BioSciences position peaked at $379K in Q1 2022.
  • 273 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2022.

Based on American Trust's 13F filing for Q4 2022, filed 16 Feb 2023.